111 related articles for article (PubMed ID: 2807883)
1. Circulating immune complexes and chemotherapy response in patients with head and neck cancer.
Blazar BA; Fried MP; Strome M; Clark JR; Sereno P; Rodliff S; Caminear D
Head Neck; 1989; 11(5):431-6. PubMed ID: 2807883
[TBL] [Abstract][Full Text] [Related]
2. Immunologic determinants of head and neck cancer response to induction chemotherapy.
Schantz SP; Savage HE; Racz T; Liu FJ; Brown BW; Rossen RD; Hong WK
J Clin Oncol; 1989 Jul; 7(7):857-64. PubMed ID: 2472470
[TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.
Dasmahapatra KS; Citrin P; Hill GJ; Yee R; Mohit-Tabatabai MA; Rush BF
J Clin Oncol; 1985 Nov; 3(11):1486-9. PubMed ID: 4056841
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.
Sridhar KS; Ohnuma T; Biller H; Holland JF; Ambinder EP; Barba J
Am J Clin Oncol; 1985 Feb; 8(1):55-60. PubMed ID: 2581436
[TBL] [Abstract][Full Text] [Related]
6. A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN).
Camille N; Rozehnal J; Roy E; Uczkowski D; Olson A; Genden E; Teng M; Bakst R; Gupta V; Posner M; Misiukiewicz K
Oral Oncol; 2017 Aug; 71():99-104. PubMed ID: 28688700
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer.
Cognetti F; Pinnarö P; Ruggeri EM; Carlini P; Perrino A; Impiombato FA; Calabresi F; Chilelli MG; Giannarelli D
J Clin Oncol; 1989 Jul; 7(7):829-37. PubMed ID: 2472469
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region.
Fountzilas G; Daniilidis J; Sridhar KS; Kalogera-Fountzila A; Zaramboukas T; Sombolos K; Destouni-Salem E; Vritsios A; Tourkantonis A
Cancer; 1990 Oct; 66(7):1453-60. PubMed ID: 1698526
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of circulating immune complexes in malignant tumours of head and neck.
Das TK; Aziz M; Rattan A; Sherwani R
J Indian Med Assoc; 1995 Jan; 93(1):3-7. PubMed ID: 7759908
[TBL] [Abstract][Full Text] [Related]
11. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
[TBL] [Abstract][Full Text] [Related]
12. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of head and neck cancer].
Kohno N; Nakazawa E; Kusunoki M; Nishiya M
Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
[TBL] [Abstract][Full Text] [Related]
15. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck.
Posner MR; Glisson B; Frenette G; Al-Sarraf M; Colevas AD; Norris CM; Seroskie JD; Shin DM; Olivares R; Garay CA
J Clin Oncol; 2001 Feb; 19(4):1096-104. PubMed ID: 11181674
[TBL] [Abstract][Full Text] [Related]
16. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
17. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Wright JE; Norris CM; Busse PM; Lucarini JW; Fallon BG; Casey D; Andersen JW; Klein R
Ann Intern Med; 1990 Feb; 112(3):167-72. PubMed ID: 2297193
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease.
Recondo G; Cvitkovic E; Azli N; Tellez Bernal E; de Vathaire F; Wibault P; Richard JM; Marandas P; Benahmed M; Domenge C
Cancer; 1991 Nov; 68(10):2109-19. PubMed ID: 1717121
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group study.
Fountzilas G; Kosmidis P; Sridhar KS; Kalogera-Fountzila A; Banis K; Dimitriadis A; Avramidis V; Nikolaou A; Zaramboukas T; Skarlos D; Vritsios A; Daniilidis I
Cancer Invest; 1996; 14(3):189-96. PubMed ID: 8630678
[TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy in head and neck cancer: results of a phase III trial.
Mazeron JJ; Martin M; Brun B; Grimard L; Lelièvre G; Vergnes L; Haddad E; Feuilhade F; Piedbois P; Strunski W
Head Neck; 1992; 14(2):85-91. PubMed ID: 1376306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
